Alkermes : ALKS

All Alkermes Articles

94 Articles

Jon C. Ogg | May 29, 2013 at 8:20 AM EDT

Top Analyst Upgrades and Stocks to Buy: Alkermes, Sonus Networks and More

Investors and traders are always on the hunt for new research ideas that will lead to higher income or more profits.…

Jon C. Ogg | Apr 22, 2013 at 8:25 AM EDT

Top Analyst Downgrades and Cautious Views from Wall Street

Jon OggInvestors are used to seeing many Buy ratings from Wall St. analysts, but they often overlook or do not…

Jon C. Ogg | Apr 17, 2013 at 11:45 AM EDT

Merrill Lynch Offers Four Key Biotech Drug Updates

ThinkstockBiotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap…

Jon C. Ogg | Feb 6, 2013 at 10:05 AM EST

Years Later, MS Drug Ownership Consolidation — M&A Next?

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes “better…

Jon C. Ogg | Jan 17, 2013 at 8:42 AM EST

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls…

Jon C. Ogg | Oct 26, 2012 at 8:14 AM EDT

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday.…

Jon C. Ogg | Oct 18, 2012 at 8:37 AM EDT

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls…

Jon C. Ogg | Aug 13, 2012 at 2:05 PM EDT

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit,…

Jon C. Ogg | Jul 11, 2012 at 8:24 AM EDT

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday.…

Jon C. Ogg | Mar 28, 2012 at 9:52 AM EDT

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …

Jon C. Ogg | Feb 16, 2012 at 5:59 PM EST

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

Alkermes plc (NASDAQ: ALKS) has filed its paperwork with the Securities and Exchange Commission for the resale covering the potential…

Jon C. Ogg | Jan 30, 2012 at 2:27 PM EST

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is up 17.8% at $14.29 on word that the FDA finally gave its once-a-week diabetes…

Jon C. Ogg | Sep 26, 2011 at 8:25 AM EDT

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Sep 14, 2011 at 8:12 AM EDT

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | May 14, 2011 at 10:16 AM EDT

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

Jon OggEach morning during the week we publish the top analyst upgrades and downgrades that we see in the market. …

1 … 3 4 5 6 7

Alkermes : ALKS

All Alkermes Articles

Top Analyst Upgrades and Stocks to Buy: Alkermes, Sonus Networks and More

Top Analyst Downgrades and Cautious Views from Wall Street

Merrill Lynch Offers Four Key Biotech Drug Updates

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

Alkermes : ALKS

All Alkermes Articles

Top Analyst Upgrades and Stocks to Buy: Alkermes, Sonus Networks and More

Top Analyst Downgrades and Cautious Views from Wall Street

Merrill Lynch Offers Four Key Biotech Drug Updates

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ADTN, ALKS, CBS, CSCO, GLW, DCI, ERJ, INCY, JNPR, MJN, MDT, REGN, SAP, LUV, VVUS, YUM, ZLTQ)

Top Analyst Upgrades and Downgrades (ALKS, AVT, KMX, CTCT, CME, DK, EXPD, HBAN, MPC, MYL, P, PSX, RCL, SPR, STJ, TRV)

Top Analyst Upgrades and Downgrades (ALKS, NLY, AAPL, APOL, CMA, COP, DB, DUK, HOG, INTC, LINE, POT, SDRL, STJ, VVUS, Z)

Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)

Top Analyst Upgrades & Downgrades (AA, ALKS, AMZN, AAPL, BHP, CENX, CLF, CRK, DNDN, DUK, EMC, FST, HAL, IBM, MSFT, PAL, SAP, SPLS, WM)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Elan Shares of Alkermes Registered For Sale (ALKS, ELN)

The Amylin Gains Could Have Even Been Larger (AMLN, ALKS, NVO)

Top Analyst Upgrades & Downgrades (AMD, ALKS, AMSG, ERTS, EXPE, FSLR, GXP, GMCR, GPRE, ITRI, NFLX, OXY, SLE, UTX)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Top 6 Analyst Calls of the Week (ALKS, APO, DF, ETFC, PNSN, SPWRA)

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

Featured Reads

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.